Attached files

file filename
EX-3.1 - RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT, AS AMENDED. - ICAGEN INCdex31.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO EXCHANGE ACT RULE 13A-14(A) - ICAGEN INCdex312.htm
EX-10.6 - SUMMARY OF DIRECTOR COMPENSATION - ICAGEN INCdex106.htm
EX-31.1 - CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO EXCHANGE ACT RULE 13A-14(A) - ICAGEN INCdex311.htm
EX-32.1 - CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO 18 U.S.C. SECTION 1350 - ICAGEN INCdex321.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ICAGEN INCdex231.htm
EX-10.7 - SUMMARY OF 2011 BONUS TARGETS - ICAGEN INCdex107.htm
10-K - FORM 10-K - ICAGEN INCd10k.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Icagen, Inc. (the “Company”) for the period ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Richard D. Katz, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 9, 2011  

/s/ Richard D. Katz

  Richard D. Katz, M.D.
  Chief Financial Officer